Home › Idiopathic Thrombocytopenic Purpura

Idiopathic Thrombocytopenic Purpura clinical trials recruiting in the U.S.

17 studies for Idiopathic Thrombocytopenic Purpura are recruiting participants at sites across the United States.

Cities with the most studies

• Los Angeles, CA7 studies
• Greenville, NC6 studies
• Washington, DC6 studies
• Boston, MA6 studies
• The Bronx, NY5 studies
• Portland, OR4 studies
• Seattle, WA4 studies
• Durham, NC4 studies
• Houston, TX4 studies
• Rochester, MN4 studies
• Cedar Rapids, IA3 studies
• Philadelphia, PA3 studies
• Cleveland, OH3 studies
• New Orleans, LA3 studies
• New Haven, CT3 studies

By state

• Arkansas3 studies
• California10 studies
• Connecticut3 studies
• District of Columbia6 studies
• Florida3 studies
• Illinois4 studies
• Iowa3 studies
• Louisiana4 studies
• Massachusetts6 studies
• Michigan3 studies
• Minnesota5 studies
• New Jersey4 studies
• New York7 studies
• North Carolina7 studies
• Ohio3 studies
• Oregon4 studies
• Pennsylvania3 studies
• Texas4 studies
• Virginia4 studies
• Washington4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.